Skip to main content
. Author manuscript; available in PMC: 2009 Sep 14.
Published in final edited form as: Biochemistry. 2005 Dec 20;44(50):16574–16583. doi: 10.1021/bi0518186

Figure 7. TU-514 protection of AaLpxC against irreversible inhibition by CHIR-090.

Figure 7

AaLpxC was preincubated alone or in the presence of TU-514, CHIR-090, or both TU-514 and CHIR-090. Samples were then assayed for activity. Control reactions were performed in which AaLpxC was assayed alone or with TU-514, CHIR-090, or both TU-514 and CHIR-090, but without a preincubation. The remaining activity is expressed as the percent of the uninhibited control.